Boston Business Journal Report: Busy Biotech Market | NECN
NECN Business

NECN Business

Boston Business Journal Report: Busy Biotech Market

BBJ editor Don Seiffert talks about the Bay State's biggest stock gainers and losers this summer

    processing...

    NEWSLETTERS

    Getty Images
    Traders work on the floor of the New York Stock Exchange on August 25, 2014 in New York City.

    While everyone enjoyed the lazy days of summer, the biotech market in the Bay State was busy, with some more than others.

    The Boston Business Journal reported on some of the biggest stock gainers and losers in Massachusetts' biotech industry this summer.

    BBJ editor Don Seiffert said large companies such as Biogen Idec and Vertex Pharmaceuticals are among the companies doing well. But large companies aren't the only ones seeing gains.

    "Smaller biotechs have also doing well," he said.

    Who has been losing? Find out in the above video. 

    For up-to-the-minute news and weather, be sure to follow us on Twitter and like us on Facebook. Sign up for our new breaking news email alerts by clicking here and download our free apps here.